Generalized Aggressive Periodontitis
10
0
0
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
30%
3 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (10)
Interaction Between Immune Cells and Bacteria Associated With Periodontitis
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
EMD for Treatment of Proximal Class-II Furcation Involvements
Amoxicillin and Metronidazole in Association With Non-surgical Therapy in Aggressive Periodontitis Treatment
Metagenomic and Immune-inflammatory Analysis of Individuals With Generalized Aggressive Periodontitis and Their Descendants.
Alternative Antibiotic Regime in the Treatment of GAgP
Triclosan as Adjunctive Therapy in the Plaque Control in Children From Generalized Aggressive Periodontitis Families.
Effects of Smoking on Non-surgical Periodontal Therapy in Generalized Aggressive Periodontitis
Effects Of Adjunctive Photodynamic Therapy To Non-Surgical Periodontal Treatment In Patients With Generalized Aggressive Periodontitis
Gene Expression Profiles in Generalized Aggressive Periodontitis: A Gene Network-based Microarray Analysis